Perkins Coie advised Xentria Inc. on the deal.Xentria Inc., a clinical-stage biotherapeutics company dedicated to developing novel therapeutics to address unmet medical needs, announced its exclusive multi-year…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
